media – Page 598 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Trigger for most common form of vision loss discovered

In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.
- Source: iran-daily
- 509
- November 30, 2017
inflammation macular degeneration Researches
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.
- Source: Businesswire
- 472
- November 30, 2017
CNS Market Views Parkinson’s disease
Codiak BioSciences Closes $76.5 Million Series C Financing

Codiak intends to use the proceeds of the Series C financing to advance its initial product candidates into clinical trials, and to continue to develop the company's transformational exosome therapeutic platform.
- Source: Businessinsider
- 597
- November 30, 2017
Clinical Trials exosome therapeutic Market Views Series
Combination HIV prevention reduces new infections by 42 percent in Ugandan district

A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections in a population.
- Source: medicalxpress
- 509
- November 30, 2017
ART HIV NIH Researches
Does Loss of REM Sleep Affect Overall Health?

In a recently published paper, researchers outline the importance of REM sleep and the causes and consequences of loss of REM sleep.
- Source: medicalnewsbulletin
- 473
- November 29, 2017
REM Sleep Researches Sleep deprivation
New Genes Associated With Cognitive Ability Identified

Investigators at The Feinstein Institute for Medical Research discovered dozens of new genetic variations associated with a person’s general cognitive ability. The findings, which were published online today in Cell Reports, have the potential to help researchers develop more targeted treatment for cognitive and memory disorders.
- Source: neurosciencenews
- 516
- November 29, 2017
Alzheimer's disease cognitive disorders Researches schizophrenia
Are Leading Global Causes of Blindness Preventable?

A recent study analyzed population-based data to determine the global causes of blindness and visual impairment and made projections by cause to 2020.
- Source: medicalnewsbulletin
- 981
- November 29, 2017
blindness Researches Visual impairment WHO
Doctolib raises another $42 million for its medical care scheduling service

French startup Doctolib is raising money for the second time in the past twelve months. The company is building a sort of Salesforce for the healthcare industry with a big emphasis on bookings. Doctolib just raised $42 million (€35 million) from Eurazeo and existing investor Bpifrance.
- Source: Technologythrill
- 457
- November 29, 2017
Doctolib Market Views Series
Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis

Biogen (Nasdaq:BIIB) and Alkermes plc (Nasdaq:ALKS) today announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel, oral, monomethyl fumarate (MMF) small drug molecule in Phase 3 development for the treatment of relapsing forms of multiple sclerosis (MS).
- Source: businesswire
- 507
- November 29, 2017
ALKS 8700 Biogen Market Views
Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority

Review Designation of Mogamulizumab’s Biologics License Application
- Source: drugdu
- 483
- November 29, 2017
Biologics License Application FDA New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.